D-0550-2026 Class III Ongoing

Recalled by AVEVA Drug Delivery Systems, Inc. — Miramar, FL

FDA drug recall D-0550-2026 was initiated by AVEVA Drug Delivery Systems, Inc. on May 14, 2026 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units. The recall status is ongoing. Affected quantity: 59,808 pouches (4,272 Individual Folding Carton (IFC)).

Recall details

Product Type
Drugs
Report Date
Jun 3, 2026
Initiation Date
May 14, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
59,808 pouches (4,272 Individual Folding Carton (IFC))

Product description

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Reason for recall

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Distribution pattern

Nationwide within the U.S

Code information

Lot #: 56841, Expires: 03/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0550-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0550-2026. Report a data issue: hello@regdatalab.com.